竹内, 正弘
Takeuchi, Masahiro
VIAF ID: 266154234 ( Personal )
Permalink: http://viaf.org/viaf/266154234
Preferred Forms
- 100 1 _ ‡a Takeuchi, Masahiro
- 100 1 _ ‡a Takeuchi, Masahiro
- 100 1 _ ‡a 竹内, 正弘
- 100 1 _ ‡a 竹内, 正弘
4xx's: Alternate Name Forms (9)
Works
Title | Sources |
---|---|
Bridging strategies, 2001: | |
Burijjingu sutorateji. | |
NIH rinsho kenkyu no kihon to jissai. | |
NIH臨床研究の基本と実際 | |
Pichi towa nanika : Tokei o sukoshizutsu rikai suru sanjuyonsho. | |
Principles of biostatistics. | |
P値とは何か : 統計を少しずつ理解する34章 | |
Seibutsu tōkeigaku nyūmon : Hābādo daigaku kōgi tekisuto | |
Shin'yaku no kaihatsu shinsa shōnin = Development, evaluation and approval of new drugs : San gaku kan no kyōryoku | |
Yakugaku no tame no iryo tokeigaku. | |
ぬるま湯からの脫却 = Moving beyond the comfort zone : the 13th Kitasato University-Harvard School of Public Health Symposium | |
ブリッジング・ストラテジー : Extrapolating clinical data to new regions for drug development | |
国際同時試験におけるアジア臨床試験の意義 = Significance of Asian studies in simultaneous global clinical trials | |
斬新な新薬開発戦略/グローバル開発への日本の貢献 = Innovative strategies for enhancing regional drug development as a global drug development | |
新薬の世界同時開発戦略 = Simultaneous, worldwide development strategies : implementation of global clinical trials and introduction of new sciences and technologies | |
新薬の開発、審査、承認 : 産・学・官の協力 = Development, evaluation and approval of new drugs : partnership between regulatory agencies, industry and academia | |
新薬の開発戦略最前線 = Forefront of new drug development strategies | |
日本版クリティカルパス・オポチュニティー = Japan's critical path opportunities | |
次世代医療を見据えた斬新な新薬開発戦略 = Innovative strategies for future objectives | |
生物統計学入門 : ハーバード大学講義テキスト | |
経験からの習得と未来への挑戦 = Learning from experience and new challenges for the future : 新薬,新医療機器のグローバル開発 | |
薬学のための医療統計学 |